HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Michele Caraglia Selected Research
Michele Caraglia Research Topics
Disease
200
Neoplasms (Cancer)
04/2024 - 07/2002
34
Neoplasm Metastasis (Metastasis)
03/2024 - 05/2006
29
Colorectal Neoplasms (Colorectal Cancer)
04/2024 - 05/2005
29
Breast Neoplasms (Breast Cancer)
09/2023 - 06/2006
23
Prostatic Neoplasms (Prostate Cancer)
12/2022 - 05/2007
17
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2023 - 05/2005
13
Brain Neoplasms (Brain Tumor)
03/2023 - 01/2006
13
Colonic Neoplasms (Colon Cancer)
01/2023 - 07/2005
13
Melanoma (Melanoma, Malignant)
03/2021 - 12/2004
10
Squamous Cell Carcinoma of Head and Neck
03/2024 - 01/2006
10
Adenocarcinoma
02/2024 - 05/2007
9
Carcinogenesis
06/2023 - 07/2015
9
Hepatocellular Carcinoma (Hepatoma)
03/2019 - 01/2010
8
Inflammation (Inflammations)
01/2023 - 07/2013
8
Glioblastoma (Glioblastoma Multiforme)
05/2022 - 10/2009
8
Carcinoma (Carcinomatosis)
05/2021 - 07/2005
7
Multiple Myeloma
12/2017 - 10/2012
7
Pancreatic Neoplasms (Pancreatic Cancer)
01/2014 - 05/2005
6
Head and Neck Neoplasms (Head and Neck Cancer)
11/2020 - 05/2005
5
Osteosarcoma (Osteogenic Sarcoma)
06/2022 - 07/2007
5
Urinary Bladder Neoplasms (Bladder Cancer)
06/2021 - 02/2010
5
Hematologic Neoplasms (Hematological Malignancy)
03/2018 - 12/2011
5
Bone Diseases (Bone Disease)
07/2013 - 05/2006
4
Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2023 - 04/2003
4
Stomach Neoplasms (Stomach Cancer)
04/2022 - 12/2005
4
COVID-19
01/2021 - 01/2020
4
Pneumonia (Pneumonitis)
01/2020 - 12/2005
4
Pain (Aches)
06/2017 - 02/2008
4
Metabolic Syndrome (Dysmetabolic Syndrome X)
05/2017 - 01/2014
4
medullary Thyroid cancer
01/2017 - 10/2013
4
Renal Cell Carcinoma (Grawitz Tumor)
11/2016 - 12/2004
4
Cardiotoxicity
06/2014 - 03/2005
3
Lymphatic Metastasis
02/2024 - 01/2018
3
Circulating Neoplastic Cells
03/2022 - 01/2020
3
Laryngeal Neoplasms (Laryngeal Cancer)
03/2022 - 07/2019
Drug/Important Bio-Agent (IBA)
36
MicroRNAs (MicroRNA)
IBA
03/2024 - 10/2012
23
Biomarkers (Surrogate Marker)
IBA
03/2023 - 01/2009
23
Proteins (Proteins, Gene)
FDA Link
03/2023 - 05/2007
23
Zoledronic Acid (Zometa)
FDA Link
10/2018 - 09/2004
16
Monoclonal Antibodies
IBA
12/2023 - 05/2005
13
Fluorouracil (Carac)
FDA Link
Generic
04/2024 - 05/2005
13
Cytokines
IBA
12/2022 - 12/2004
13
Gemcitabine
FDA Link
01/2014 - 07/2005
12
Doxorubicin (Adriamycin)
FDA Link
Generic
10/2018 - 03/2005
11
ErbB Receptors (EGF Receptor)
IBA
11/2016 - 04/2003
10
Diphosphonates (Bisphosphonates)
IBA
05/2022 - 06/2006
10
S-Adenosylmethionine (Ademetionine)
IBA
06/2021 - 09/2015
9
Oxaliplatin (Eloxatin)
FDA Link
Generic
04/2024 - 07/2004
9
Bevacizumab (Avastin)
FDA Link
01/2021 - 05/2005
9
Peptides (Polypeptides)
IBA
01/2020 - 07/2005
9
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
09/2017 - 05/2005
8
Immune Checkpoint Inhibitors
IBA
08/2022 - 11/2016
8
Cetuximab (Erbitux)
FDA Link
01/2019 - 05/2005
8
Cisplatin (Platino)
FDA Link
Generic
01/2019 - 04/2009
8
Sorafenib (BAY 43-9006)
FDA Link
02/2018 - 01/2010
7
urotensin II
IBA
03/2020 - 01/2011
7
Tyrosine Kinase Inhibitors
IBA
04/2019 - 04/2003
7
Liposomes (Liposome)
IBA
03/2019 - 07/2008
7
Hormones (Hormone)
IBA
01/2018 - 09/2010
7
Temozolomide (Temodar)
FDA Link
Generic
11/2014 - 01/2006
6
Irinotecan (Camptosar)
FDA Link
Generic
04/2024 - 05/2005
6
Lipids
IBA
01/2021 - 01/2014
6
Antineoplastic Agents (Antineoplastics)
IBA
07/2017 - 07/2008
6
Interferon-alpha (Interferon Alfa)
IBA
11/2009 - 02/2003
6
Leucovorin (Folinic Acid)
FDA Link
11/2007 - 05/2005
5
DNA (Deoxyribonucleic Acid)
IBA
03/2022 - 06/2008
5
Androgens
IBA
10/2021 - 05/2007
5
polydatin
IBA
01/2021 - 10/2013
5
Enzymes
IBA
04/2019 - 06/2007
5
Ligands
IBA
01/2019 - 01/2013
5
fotemustine (Muphoran)
IBA
01/2019 - 10/2009
5
Reactive Oxygen Species (Oxygen Radicals)
IBA
10/2018 - 10/2011
5
Gefitinib (Iressa)
FDA Link
11/2016 - 04/2003
5
Antioxidants
IBA
04/2016 - 07/2006
5
Interferon Type I
IBA
01/2014 - 06/2009
5
Epidermal Growth Factor (EGF)
IBA
06/2006 - 09/2004
4
Long Noncoding RNA
IBA
01/2023 - 07/2019
4
Docetaxel (Taxotere)
FDA Link
01/2021 - 03/2009
4
Phosphotransferases (Kinase)
IBA
01/2018 - 06/2006
4
Drug Combinations
IBA
12/2017 - 10/2005
4
Etoposide (VP 16)
FDA Link
Generic
09/2017 - 05/2010
4
Endocrine Disruptors
IBA
05/2017 - 07/2015
4
Histone Deacetylase Inhibitors
IBA
01/2017 - 06/2007
4
Messenger RNA (mRNA)
IBA
01/2017 - 03/2010
4
Histone Deacetylases (Histone Deacetylase)
IBA
01/2017 - 06/2007
4
Anthracyclines
IBA
04/2016 - 07/2007
3
Therapeutic Uses
IBA
06/2023 - 01/2013
3
Antigens
IBA
03/2023 - 07/2005
3
Circulating Tumor DNA
IBA
01/2022 - 10/2019
3
Androgen Receptors (Androgen Receptor)
IBA
10/2021 - 01/2013
3
Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)
IBA
09/2021 - 07/2002
3
Nucleic Acids
IBA
09/2020 - 01/2014
3
Everolimus
FDA Link
01/2020 - 01/2017
3
Ruthenium
IBA
01/2020 - 01/2017
Therapy/Procedure
69
Therapeutics
12/2023 - 05/2004
45
Drug Therapy (Chemotherapy)
04/2024 - 07/2004
19
Radiotherapy
03/2023 - 01/2007
8
Immunotherapy
08/2022 - 07/2005
6
Castration
10/2021 - 09/2010
3
Prostatectomy (Retropubic Prostatectomy)
06/2022 - 08/2015